{
    "clinical_study": {
        "@rank": "26796", 
        "arm_group": {
            "arm_group_label": "negative pressure dressing vs. standard of care", 
            "arm_group_type": "Experimental", 
            "description": "single arm study- randomized Prevena vac or standard of care"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine the effects of Prevena therapy on decreasing groin\n      surgical site infections in patients who are obese and /or diabetic having vascular surgery."
        }, 
        "brief_title": "Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obesity", 
            "Diabetes", 
            "Peripheral Vascular Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Vascular Diseases", 
                "Peripheral Vascular Diseases", 
                "Peripheral Arterial Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients who are obese and/or diabetic may have poor surgical healing and infection rates\n      higher. The PREVENA therapy will be used to evaluate possible reduction of infection rates\n      in this patient population"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  subjects over 18 years old\n\n          -  obese (BMI > 30) and or diabetic\n\n        Exclusion Criteria:\n\n          -  current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to\n             adhesive, sensitivity to silver"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "276", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983215", 
            "org_study_id": "2013H0045"
        }, 
        "intervention": {
            "arm_group_label": "negative pressure dressing vs. standard of care", 
            "intervention_name": "Prevena vac", 
            "intervention_type": "Device", 
            "other_name": "randomized 1:1 negative pressure dressing vs. standard of care"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "groin incisions", 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "Ohio State Division of Vascular Diseases and Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "EFFECTS OF PREVENA THERAPY ON REDUCTION OF GROIN SURGICAL SITE INFECTIONS IN OBESE PATIENTS UNDERGOING VASCULAR SURGERY", 
        "overall_official": {
            "affiliation": "The Ohio State Medical Center", 
            "last_name": "Jean E Starr, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "reduction of 30 day surgical site infection by evaluating infection rates in obese, diabetic patients who were randomized to Prevena Vac vs. standard of care", 
            "measure": "number of patients with infections", 
            "safety_issue": "No", 
            "time_frame": "30 day post surgical procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983215"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Ohio State University", 
            "investigator_full_name": "Dr. Jean E. Starr, MD", 
            "investigator_title": "Vascular surgeon", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "reduction of 1 year graft infection in prosthetic grafts and reduction of secondary hospitalizations for infection.Patients will be followed through 1 year to measure results of infection rates and secondary hospitalization related to infection", 
            "measure": "infection rates", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Ohio State University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Jean E. Starr, MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}